acrolein has been researched along with Experimental Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, H; Huang, Y; Luo, J; Luo, X; Tan, T; Wang, N; Wang, Y; Yang, C; Yang, S; Zhang, L | 1 |
| Ai, Y; Lu, S; Obianom, ON | 1 |
| Bae, WY; Choi, JS; Jeong, JW; Kim, JE | 1 |
| Madondo, MT; Plebanski, M; Quinn, M | 1 |
| ALARCON, RA | 1 |
| Dolan, ME; Hansen, RJ; Ludeman, SM; Paikoff, SJ; Pegg, AE | 1 |
| Georgieva, MP; Kabaivanov, VS; Popov, DV; Zacharieva, EI | 1 |
| Feron, VJ; Kruysse, A | 1 |
| Lelieveld, P; van Putten, LM | 1 |
| Cox, PJ; Farmer, PB; Foster, AB; Gilby, ED; Jarman, M | 1 |
1 review(s) available for acrolein and Experimental Neoplasms
| Article | Year |
|---|---|
Low dose cyclophosphamide: Mechanisms of T cell modulation.
Topics: Acrolein; Adenosine Triphosphate; Animals; Antineoplastic Agents, Alkylating; Biotransformation; Cell Cycle; Cross-Linking Reagents; Cyclophosphamide; Cytotoxicity, Immunologic; DNA Damage; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neoplasms; Neoplasms, Experimental; Oxidative Stress; Prodrugs; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2016 |
9 other study(ies) available for acrolein and Experimental Neoplasms
| Article | Year |
|---|---|
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Bone Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Topics: Acrolein; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship | 2018 |
Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression.
Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; TOR Serine-Threonine Kinases | 2015 |
ISOLATION OF ACROLEIN FROM INCUBATED MIXTURES OF SPERMINE WITH CALF SERUM AND ITS EFFECTS ON MAMMALIAN CELLS.
Topics: Acrolein; Aldehydes; Amines; Animals; Blood; Cattle; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 180; Spermine; Tissue Culture Techniques | 1964 |
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.
Topics: Acetaldehyde; Acrolein; Alkylating Agents; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclophosphamide; DNA Repair; Drug Resistance, Neoplasm; Ifosfamide; Mice; Mice, Knockout; Mutation; Neoplasms, Experimental; O(6)-Methylguanine-DNA Methyltransferase; Recombinant Proteins; Transfection; Transplantation, Heterologous | 2007 |
Preparation and investigation of cross-linked copolymers containing antitumour agents.
Topics: Acrolein; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Melphalan; Mice; Neoplasms, Experimental; Polymers; Polymethacrylic Acids; Polyvinyls; Vinyl Compounds | 1983 |
Effects of exposure to acrolein vapor in hamsters simultaneously treated with benzo[a]pyrene or diethylnitrosamine.
Topics: Acrolein; Aerosols; Aldehydes; Animals; Benzopyrenes; Body Weight; Carcinogens; Cricetinae; Diethylnitrosamine; Female; Male; Mesocricetus; Neoplasms, Experimental; Nitrosamines; Organ Size; Respiratory Tract Neoplasms; Time Factors | 1977 |
Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
Topics: Acrolein; Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Hydroxylation; Ifosfamide; Leukemia L1210; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasms, Experimental; Nitrogen Mustard Compounds; Osteosarcoma; Oxazines | 1976 |
The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
Topics: Acrolein; Animals; Antineoplastic Agents; Cyclophosphamide; Deuterium; Female; Humans; Hydroxylation; In Vitro Techniques; Mass Spectrometry; Mice; Mice, Inbred BALB C; Microsomes, Liver; Neoplasms, Experimental; Nitrogen Mustard Compounds; Radiochemistry; Rats; Stereoisomerism | 1976 |